PULMATRIX, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
PULMATRIX, INC. (PULM) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$74.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-03-13
- PULMATRIX, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$38.00K, a 733.33% decline year-over-year.
- PULMATRIX, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$23.00K.
- PULMATRIX, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $6.00K.
- PULMATRIX, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$265.00K.
- PULMATRIX, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$74.00K.
- PULMATRIX, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$431.00K, a 104.58% decline from fiscal 2015.
- PULMATRIX, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $9.40M.
- PULMATRIX, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$156.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$61.00K derived: sum of 2 quarters · filed 2018-03-13 | -$74.00K 10-K · filed 2018-03-13 | |
| 2017-09-30 | -$23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$36.00K 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | -$13.00K 10-Q · filed 2017-08-04 | |||
| 2016-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$259.00K derived: sum of 2 quarters · filed 2018-03-13 | -$358.00K derived: sum of 3 quarters · filed 2018-03-13 | -$431.00K 10-K · filed 2018-03-13 |
| 2016-09-30 | -$265.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$364.00K derived: sum of 2 quarters · filed 2017-11-09 | -$437.00K 10-Q · filed 2017-11-09 | -$583.00K derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | -$99.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$172.00K 10-Q · filed 2017-08-04 | -$318.00K derived: sum of 3 quarters · filed 2017-08-04 | -$388.00K derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-03-31 | -$73.00K 10-Q · filed 2016-05-05 | -$219.00K derived: sum of 2 quarters · filed 2017-03-10 | -$289.00K derived: sum of 3 quarters · filed 2017-03-10 | $9.35M derived: sum of 4 quarters · filed 2017-03-10 |
| 2015-12-31 | -$146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$216.00K derived: sum of 2 quarters · filed 2017-03-10 | $9.42M derived: sum of 3 quarters · filed 2017-03-10 | $9.40M 10-K · filed 2017-03-10 |
| 2015-09-30 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $9.57M derived: sum of 2 quarters · filed 2016-11-04 | $9.55M 10-Q · filed 2016-11-04 | $9.55M derived: sum of 4 quarters · filed 2016-11-04 |
| 2015-06-30 | $9.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $9.62M 10-Q · filed 2016-08-04 | $9.62M derived: sum of 3 quarters · filed 2016-08-04 | $9.52M derived: sum of 4 quarters · filed 2016-08-04 |
| 2015-03-31 | -$19.00K 10-Q · filed 2016-05-05 | -$19.00K derived: sum of 2 quarters · filed 2016-05-05 | -$121.00K derived: sum of 3 quarters · filed 2016-05-05 | -$156.00K 10-K · filed 2015-06-10 |
| 2014-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | -$102.00K derived: sum of 2 quarters · filed 2015-02-13 | -$103.00K 10-Q · filed 2015-02-13 | -$285.00K 10-K · filed 2016-03-10 |
| 2014-09-30 | -$102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | -$103.00K 10-Q · filed 2014-11-13 | -$218.00K 10-Q · filed 2015-11-12 | -$103.00K derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-06-30 | -$1.00K 10-Q · filed 2014-08-14 | -$195.00K 10-Q · filed 2015-08-14 | -$1.00K derived: sum of 3 quarters · filed 2015-06-10 | -$1.00K derived: sum of 4 quarters · filed 2015-06-10 |
| 2014-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | $0.00 derived: sum of 2 quarters · filed 2015-06-10 | $0.00 derived: sum of 3 quarters · filed 2015-06-10 | $0.00 10-K · filed 2015-06-10 |
| 2013-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | $0.00 derived: sum of 2 quarters · filed 2015-02-13 | $0.00 10-Q · filed 2015-02-13 | |
| 2013-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $0.00 10-Q · filed 2014-11-13 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |